Workshop C: Advancing Modality Innovation in Dermatology: Matching Biology with the Right Therapeutic Platform
Time: 1:00 pm
day: PRE-CONFERENCE WORKSHOP DAY Track A P2
Details:
With expanding insights into the molecular drivers of dermatologic diseases, discovery and early development teams are increasingly tasked with aligning the right therapeutic modality to complex biological targets. From immune engagement to genetic correction, this workshop explores how new formats like bispecifics, gene therapies, and oligonucleotides are reshaping the future of skin-targeted
treatments.
Key Objectives
- Emerging Immune-Engaging Modalities: Bispecifics, trispecifics, and nanobodies for selective immune modulation in dermatologic disease
- Genetic & RNA-Based Approaches: Leveraging gene therapies, siRNA, and antisense technologies to address monogenic and inflammatory skin conditions
- Modality x Route of Administration: Evaluating how topical, oral, subcutaneous, or intradermal routes influence efficacy, tissue penetration, and durability
- Early Modality Selection Strategy: Key considerations for choosing the optimal format based on target biology, disease mechanism, and translation potential
Speakers:
